Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

UB-165

From Wikipedia, the free encyclopedia
Pharmaceutical drug
Pharmaceutical compound
UB-165
Identifiers
  • (1R,6R)-5-(6-chloropyridin-3-yl)-9-azabicyclo[4.2.1]non-4-ene
CAS Number
PubChemCID
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC13H15ClN2
Molar mass234.73 g·mol−1
3D model (JSmol)
  • c2nc(Cl)ccc2C1=CCCC3CCC1N3
  (verify)

UB-165 is adrug which acts as anagonist atneuronalnicotinic acetylcholine receptors being afull agonist of theα3β2 isoform and apartial agonist of theα4β2* isoform. It is used to study the role of this receptor subtype in the release ofdopamine andnoradrenaline in the brain,[1][2] and has also been used as alead compound to derive a number of other selective nicotinic receptor ligands.[3][4][5][6]

References

[edit]
  1. ^Sharples CG, Kaiser S, Soliakov L, Marks MJ, Collins AC, Washburn M, et al. (April 2000)."UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes".The Journal of Neuroscience.20 (8):2783–91.doi:10.1523/JNEUROSCI.20-08-02783.2000.PMC 6772190.PMID 10751429.
  2. ^Cao YJ, Surowy CS, Puttfarcken PS (March 2005). "Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus".The Journal of Pharmacology and Experimental Therapeutics.312 (3):1298–304.doi:10.1124/jpet.104.076794.PMID 15542623.S2CID 20437091.
  3. ^Gohlke H, Gündisch D, Schwarz S, Seitz G, Tilotta MC, Wegge T (February 2002). "Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165".Journal of Medicinal Chemistry.45 (5):1064–72.doi:10.1021/jm010936y.PMID 11855986.
  4. ^Sharples CG, Karig G, Simpson GL, Spencer JA, Wright E, Millar NS, et al. (July 2002). "Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165".Journal of Medicinal Chemistry.45 (15):3235–45.doi:10.1021/jm020814l.PMID 12109907.
  5. ^Sutherland A, Gallagher T, Sharples CG, Wonnacott S (March 2003). "Synthesis of two fluoro analogues of the nicotinic acetylcholine receptor agonist UB-165".The Journal of Organic Chemistry.68 (6):2475–8.doi:10.1021/jo026698b.PMID 12636420.
  6. ^Karig G, Large JM, Sharples CG, Sutherland A, Gallagher T, Wonnacott S (September 2003). "Synthesis and nicotinic binding of novel phenyl derivatives of UB-165. Identifying factors associated with alpha7 selectivity".Bioorganic & Medicinal Chemistry Letters.13 (17):2825–8.doi:10.1016/S0960-894X(03)00594-8.PMID 14611837.
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
nAChRsTooltip Nicotinic acetylcholine receptors
Agonists
(andPAMsTooltip positive allosteric modulators)
Antagonists
(andNAMsTooltip negative allosteric modulators)
Precursors
(andprodrugs)
Retrieved from "https://en.wikipedia.org/w/index.php?title=UB-165&oldid=1215135741"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp